Exact Sciences Corporation

DB:EXK Stock Report

Market Cap: €10.6b

Exact Sciences Management

Management criteria checks 2/4

Exact Sciences' CEO is Kevin Conroy, appointed in Apr 2009, has a tenure of 15.08 years. total yearly compensation is $16.12M, comprised of 6.5% salary and 93.5% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth €41.04M. The average tenure of the management team and the board of directors is 3.3 years and 4.8 years respectively.

Key information

Kevin Conroy

Chief executive officer

US$16.1m

Total compensation

CEO salary percentage6.5%
CEO tenure15.1yrs
CEO ownership0.4%
Management average tenure3.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kevin Conroy's remuneration changed compared to Exact Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$16mUS$1m

-US$204m

Sep 30 2023n/an/a

-US$282m

Jun 30 2023n/an/a

-US$432m

Mar 31 2023n/an/a

-US$517m

Dec 31 2022US$14mUS$510k

-US$624m

Sep 30 2022n/an/a

-US$716m

Jun 30 2022n/an/a

-US$735m

Mar 31 2022n/an/a

-US$745m

Dec 31 2021US$15mUS$963k

-US$596m

Sep 30 2021n/an/a

-US$793m

Jun 30 2021n/an/a

-US$829m

Mar 31 2021n/an/a

-US$720m

Dec 31 2020US$20mUS$499k

-US$824m

Sep 30 2020n/an/a

-US$327m

Jun 30 2020n/an/a

-US$165m

Mar 31 2020n/an/a

-US$136m

Dec 31 2019US$19mUS$792k

-US$213m

Sep 30 2019n/an/a

-US$216m

Jun 30 2019n/an/a

-US$221m

Mar 31 2019n/an/a

-US$219m

Dec 31 2018US$7mUS$696k

-US$175m

Sep 30 2018n/an/a

-US$143m

Jun 30 2018n/an/a

-US$124m

Mar 31 2018n/an/a

-US$119m

Dec 31 2017US$13mUS$633k

-US$114m

Compensation vs Market: Kevin's total compensation ($USD16.12M) is above average for companies of similar size in the German market ($USD5.31M).

Compensation vs Earnings: Kevin's compensation has increased whilst the company is unprofitable.


CEO

Kevin Conroy (57 yo)

15.1yrs

Tenure

US$16,119,899

Compensation

Mr. Kevin T. Conroy served as Independent Director of SomaLogic, Inc. since September 1, 2021, until January 2022. Mr. Conroy had served as an Independent Director of Adaptive Biotechnologies Corporation s...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Conroy
Chairman of The Board & CEO15.1yrsUS$16.12m0.39%
$ 41.0m
Jeffrey Elliott
EVP & CFO7.5yrsUS$4.08m0.0073%
$ 771.7k
Jake Orville
Executive VP & General Manager of Pipelineno dataUS$3.67m0.0085%
$ 896.8k
Everett Cunningham
Chief Commercial Officer & Executive VP3.3yrsUS$4.55m0.026%
$ 2.7m
Brian Baranick
Executive VP & General Manager of Precision Oncologyno dataUS$3.57m0.0075%
$ 791.8k
Jorge Garces
Chief Science Officer3.1yrsno datano data
Nassar Nizami
Chief Information Officer1.3yrsno datano data
Megan Jones
Associate Manager of Investor Relationsno datano datano data
Tim Caprez
Chief Compliance Counsel & VP9.3yrsno datano data
James Herriott
Senior VP2.3yrsno data0.0060%
$ 637.1k
Sarah Condella
Executive Vice President of Human Resources7yrsUS$2.71m0.043%
$ 4.5m
Graham Lidgard
Emeritus Chief Science Officer3.3yrsUS$4.21mno data

3.3yrs

Average Tenure

49yo

Average Age

Experienced Management: EXK's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin Conroy
Chairman of The Board & CEO15.2yrsUS$16.12m0.39%
$ 41.0m
Daniel Levangie
Independent Director13.8yrsUS$408.75k0.013%
$ 1.3m
Timothy Scannell
Directorless than a yearUS$362.81k0.0031%
$ 328.6k
D. Coward
Director1.4yrsUS$1.47m0.027%
$ 2.8m
Katherine Zanotti
Independent Director15.1yrsUS$406.25k0.035%
$ 3.7m
Paul Clancy
Independent Director3.2yrsUS$417.75k0.0080%
$ 848.0k
Freda Lewis-Hall
Independent Director4.1yrsUS$402.75k0.011%
$ 1.1m
Kathleen Sebelius
Independent Director5.2yrsUS$411.75k0.014%
$ 1.4m
Shacey Petrovic
Independent Director3.8yrsUS$401.25k0.0095%
$ 1.0m
James Doyle
Lead Independent Director9.8yrsUS$442.75k0.027%
$ 2.9m
Pierre Jacquet
Independent Director4.8yrsUS$401.25k0.013%
$ 1.4m

4.8yrs

Average Tenure

61yo

Average Age

Experienced Board: EXK's board of directors are considered experienced (4.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.